International comparison of methods to risk assess patients presenting with upper gastrointestinal bleeding

International multicentre prospective study to compare risk scoring system for patients presenting with upper gastrointestinal bleeding

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN16235737

Enrollment

3000

Registered

2015-09-29

Start date

2014-03-04

Completion date

Unknown

Last updated

2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal bleeding (UGIB) Digestive System

Interventions

This is an international observational study across seven international sites, to compare five established risk assessment scores in the prediction of clinical outcomes for patients presenting with UG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients presenting with haematemesis, coffee-ground vomit, melaena 2. Patients presenting with haematochezia and circulatory insufficiency (heart rate >100 bpm and/or systolic blood pressure <100 mmHg)

Exclusion criteria

Exclusion criteria: Patients who have an UGIB whilst already an in-patient for other reasons

Design outcomes

Primary

Measure	Time frame
Need for hospital-based intervention or 30-day mortality on follow-up	—

Secondary

Measure	Time frame
1. Rebleeding within 7 days 2. Length of hospital stay	—

Countries

Canada, Denmark, England, Italy, New Zealand, Singapore, United Kingdom, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 27, 2026